Ester-C® with calcium, bioflavonoids, and Bioperine®
Natural health product licensed in Canada
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 1,200 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Ascorbate de calcium | 600 mg | 1,200,000 µg |
| Piperine Source : Fruit(s) | 3 mg | Not calculated |
| Piperine Source : Piper nigrum | 3 mg | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus sinensis Potency : 50 % Hesperidin | 150 mg | Not calculated |
| Bioflavonoïdes d'agrumes Source : Fruit(s) Potency : 50 % Hesperidin | 150 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Cellulose - microcrystalline, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
For the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not take during pregnancy or lactation. Do not use in individuals with known or suspected sensitivity to the listed ingredients.
Product record
- Licence holder
- Biomed International Products Corp.
- NPN or DIN-HM
- 80003499
- Status
- Active licence
- Licence date
- 28 May 2007
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80003499
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Piperine
Read the warning, when it applies and the studies cited
BLACK/WHITE PEPPER - PIPER NIGRUM
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications or any other health products, as black/white pepper/piperine may alter their effectiveness (Han 2011; Srinivasan 2007; Khajuria et al. 2002; Bano et al. 1991).1
Sources cited by Health Canada (4)
- Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. European Journal of Pharmacology 1991;41(6):615-7. PubMed
- Han HK. The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs. Expert Opinion on Drug Metabolism & Toxicology 2011;7(6):721-729. PubMed Review article
- Khajuria A, Thusu N, Zutshi U. Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomedicine 2002;9(3):224-31. PubMed
- Srinivasan K. Black Pepper and its pungent principle-piperine: a review of diverse physiological effects. Critical Reviews in Food Science and Nutrition 2007;47(8):735-748. PubMed Review article
1Note: At subtherapeutic quantities, the risk statement regarding the alteration of effectiveness is not required for products providing 25 mg or less Piper nigrum fruit per day for Class II and III applications.
Condition of application: Improve digestion.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Vermifuge/anthelmintic.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or persist for more than 2 weeks.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Ester-C® with calcium, bioflavonoids, and Bioperine®”, https://compoatlas.com/en/supplements/canada/80003499-ester-c-with-calcium-bioflavonoids-and-bioperine, updated 28 May 2007.